Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Autoantibody Landscape in Patients with Advanced Prostate Cancer
William S. Chen et al.
CLINICAL CANCER RESEARCH (2020)
E3 Ubiquitin Ligase APC/CCdh1 Regulation of Phenylalanine Hydroxylase Stability and Function
Apoorvi Tyagi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Antibody profiling of patients with prostate cancer reveals differences in antibody signatures among disease stages
Hemanth K. Potluri et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Establishment of two new predictive models for prostate cancer to determine whether to require prostate biopsy when the PSA level is in the diagnostic gray zone (4-10 ng ml(-1))
Jun Liu et al.
ASIAN JOURNAL OF ANDROLOGY (2020)
IFNγ-Induced IFIT5 Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer via miRNA Processing
U-Ging Lo et al.
CANCER RESEARCH (2019)
Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression
Shancheng Ren et al.
EUROPEAN UROLOGY (2018)
Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors
Michael F. Gowen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
A toolbox of immunoprecipitation-grade monoclonal antibodies to human transcription factors
Anand Venkataraman et al.
NATURE METHODS (2018)
Identification of Novel Biomarkers for Behcet Disease Diagnosis Using Human Proteome Microarray Approach
Chao-Jun Hu et al.
MOLECULAR & CELLULAR PROTEOMICS (2017)
Current prospects of type II interferon signaling and autoimmunity
Daniel S. Green et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer
Pierre P. Massion et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Autoantibodies: Opportunities for Early Cancer Detection
Isabel K. Macdonald et al.
TRENDS IN CANCER (2017)
Identification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray
Lina Yang et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer
Jitian Li et al.
ONCOTARGET (2016)
Detection of Early Cancer: Genetics or Immunology? Serum Autoantibody Profiles as Markers of Malignancy
Alexander Poletaev et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2015)
Human Kallikrein-2, Prostate Specific Antigen and Free-Prostate Specific Antigen in Combination to Discriminate Prostate Cancer from Benign Diseases in Syrian Patients
Dala-Maria Bachour et al.
Asian Pacific Journal of Cancer Prevention (2015)
Discovery and horizontal follow-up of an autoantibody signature in human prostate cancer
Paul J. Mintz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Preferential Autoimmune Response in Prostate Cancer to Cyclin B1 in a Panel of Tumor-Associated Antigens
Liping Dai et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
New Centromere Autoantigens Identified in Systemic Sclerosis Using Centromere Protein Microarrays
Guang Song et al.
JOURNAL OF RHEUMATOLOGY (2013)
Effects of Screening on Radical Prostatectomy Efficacy: The Prostate Cancer Intervention Versus Observation Trial
Jing Xia et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Prostate Cancer and the Increasing Role of Active Surveillance
David Gabriel Alonzo et al.
POSTGRADUATE MEDICINE (2013)
DNA methylation presents distinct binding sites for human transcription factors
Shaohui Hu et al.
ELIFE (2013)
EarlyCDTA®-Lung test: improved clinical utility through additional autoantibody assays
Caroline J. Chapman et al.
TUMOR BIOLOGY (2012)
Novel diagnostic biomarkers for prostate cancer
Chikezie O. Madu et al.
Journal of Cancer (2012)
East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians
Tomomi Kimura
CHINESE JOURNAL OF CANCER (2012)
Clinical validation of an autoantibody test for lung cancer
P. Boyle et al.
ANNALS OF ONCOLOGY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Prostate Cancer Screening-The Evidence, the Recommendations, and the Clinical Implications
Roger Chou et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Back propagation artificial neural network (BPANN) based performance analysis of diesel engine using biodiesel
Sumita Deb Barma et al.
JOURNAL OF RENEWABLE AND SUSTAINABLE ENERGY (2011)
Autoantibodies to tumor-associated antigens: reporters from the immune system
Eng M. Tan et al.
IMMUNOLOGICAL REVIEWS (2008)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells
C Agarwal et al.
NEOPLASIA (2004)
Humoral immune response to α-methylacyl-CoA racemase and prostate cancer
A Sreekumar et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Anti-angiogenic activity of inositol hexaphosphate (IP6)
I Vucenik et al.
CARCINOGENESIS (2004)
In vivo suppression of hormone-refractory prostate cancer growth by inositol hexaphosphate: Induction of insulin-like growth factor binding protein-3 and inhibition of vascular endothelial growth factor
RP Singh et al.
CLINICAL CANCER RESEARCH (2004)
Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes
RP Singh et al.
CARCINOGENESIS (2003)
Improved prostate cancer-specific survival and other disease parameters: Impact of prostate-specific antigen testing
EL Paquette et al.
UROLOGY (2002)
Cancer survival among US whites and minorities - A SEER (Surveillance, Epidemiology, and End Results) program population-based study
LX Clegg et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells
XL Zi et al.
CARCINOGENESIS (2000)
Share Paper
